.png)
Agenzia Italiana del Farmaco
home
Highlights
-
08 Apr 2026
Press releases
Regulations for AIFA Incontra and AIFA Ascolta Approved
The Agency strengthens dialogue with stakeholders and promotes listening and transparency.
-
26 Mar 2026
Press releases
The Board of Directors has given the go-ahead for reimbursing a new medicine, seven extensions of therapeutic indications and three generic equivalents
The medicines to be reimbursed include new indications for the treatment of metastatic prostate cancer, newly diagnosed multiple myeloma and hepatitis delta virus (HDV) infection, as well as a medicine for pre-exposure prophylaxis against HIV-1 infection.
-
26 Mar 2026
Information and communication
How to protect yourself from fake ‘miracle cures’: AIFA recommendations
To avoid the risk of fraud and protect yourselves from so-called ‘miracle cures’ based on stem cells, AIFA urges patients and their families to follow a few simple recommendations.
-
24 Mar 2026
Press releases
Drug negotiations: new ‘simplified’ and ‘fast-track’ procedures launched
The aim is to shorten the time taken for procedures relating to the inclusion of medicines on the reimbursement lists, whilst ensuring financial sustainability for the National Health Service.
News
15 Apr 2026
Transparency Lists
AIFA updates the Transparency Lists
10 Apr 2026
Safety of medicinal products
Meeting highlights from PRAC ( 7- 10 April 2026)
02 Apr 2026
Press releases
AIFA executives on institutional mission to Japan for the first time
27 Mar 2026
Safety of medicinal products
Levamisole: the PRAC recommendation for withdrawal from the EU market has been confirmed
24 Mar 2026
Press releases
AIFA and FIASO: a strategic alliance for patient safety, appropriate care and the sustainability of the NHS
20 Mar 2026
Safety of medicinal products
Direct Healthcare Professional Communication (DHPC) on Remsima (infliximab)
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
Media
